Last reviewed · How we verify
Bilastine oral dispersible tablets
At a glance
| Generic name | Bilastine oral dispersible tablets |
|---|---|
| Sponsor | Humanis Saglık Anonim Sirketi |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bilastine oral dispersible tablets CI brief — competitive landscape report
- Bilastine oral dispersible tablets updates RSS · CI watch RSS
- Humanis Saglık Anonim Sirketi portfolio CI